Reprise Biomedical is an early-commercial-stage biologics company in Plymouth, Minnesota, founded in 2019. It makes biologic wound and surgical matrices from porcine liver using a patented perfusion decellularization process. The process cannulates the liver's native vasculature and perfuses a mild detergent solution through the vessels, stripping cells while leaving an intact collagen scaffold with preserved vasculature. The resulting Miro product family is sold for deep, tunneling and undermining wounds and for soft tissue repair.